Arbloc Plus Adverse Reactions

Losartan Potassium and Hydrochlorothiazide: Orthostatic hypotension; pancreatitis; gastrointestinal disturbances.
Losartan Potassium: Hyperkalaemia; symptomatic anemia occurred in patient with 6 weeks after commencing therapy with Losartan Potassium, decreased hemoglobin concentrations has been reported in patients with severe renal impairment undergoing hemodialysis; atypical cutaneous lymphoid infiltrates, taste disturbances in some cases progressing to complete taste loss, it will return to normal after discontinuing therapy; raised liver enzyme values have occurred rarely in patients taking Losartan Potassium, severe acute reversible hepatotoxicity occurred in a patient who had been taking Losartan in a dose of 150 mg daily for 6 weeks; other adverse effects have been reported with angiotensin II antagonist include respiratory-tract disorders, back pain, fatigue and neutropenia.
Hydrochlorothiazide: Metabolic disturbances; hyperglycaemia and glycosuria; hyperuricemia and gout; electrolyte imbalances including hypochloraemic alkalosis, hyponatraemia and hypokalaemia; blood dyscrasias including thrombocytopenia and more rarely, granulocytopenia, leucopenia, aplastic and hemolytic anemia; other adverse effects include anorexia, gastric irritation, nausea, vomiting, constipation, diarrhea, sialadenitis, headache, dizziness, paraesthesia, impotence, yellow vision; hypersensitivity reactions include photosensitivity reactions, skin rashes, fever, pulmonary edema, anaphylaxis, and toxic epidermal necrolysis.